HCA Healthcare Inc
HCA: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$425.00 | Ndryd | Pfftwzlm |
HCA Turns In Weak Q4 on Omicron Surge; Shares Remain Fairly Valued
Narrow-moat HCA turned in fourth-quarter results that were a little weaker than we had expected, as the omicron variant surge appeared to put pressure on the firm's top and bottom lines. However, after incorporating a lower U.S. corporate tax rate assumption than we previously expected, we are maintaining our $239 fair value estimate. HCA shares look about fairly valued, despite the mid-single-digit decline after the earnings report Jan. 27.